Article
A capture-based method of prenatal cell-free DNA screening for autosomal recessive non-syndromic hearing loss.
Prenatal diagnosis - 1 Aug 2024
Mu Qian, Bai Ling, Xu Bing, Du Huawen, Jiang Zhaoyun, Huang Shasha, Gao Bo, Wu Qixi, Zhao Hanqing, Dai Pu, Jiang Yi
Abstract excerpt
OBJECTIVE: This study aimed to develop and validate a prenatal cell-free DNA (cfDNA) screening method that uses capture-based enrichment to genotype fetal autosomal recessive disorders. This method was applied in pregnancies at high risk of autosomal recessive non-syndromic hearing loss (ARNSHL) to assess its accuracy and effectiveness. METHODS: This assay measured the allele counts in both white blood cell DNA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
